Acute Ischemic Stroke Interventional Study

Clinical trial NCT03803007 · COMPLETED

Trial details

NCT number: NCT03803007
Sponsor: Acticor Biotech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2019-03-06
Primary completion: 2021-09-27
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.